Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Pfizer
Condition: Carcinoma, Non-Small-Cell Lung
NCT00321815
Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.